GLP-1s outearn OpenAI and Anthropic combined as Eli Lilly hits $1T
zebird0 · x · 2026-11-06
Founder zebird0 argues GLP-1s are the biggest market opportunity outside AI: Ozempic and Zepbound made more money last year than OpenAI and Anthropic, and Eli Lilly became the first $1T pharma company. Chart estimates 2026 GLP-1 revenue at $89B vs $70B for OpenAI+Anthropic.
Related event: Ex-a16z Speedrun Founder Raises $6M for Nasal Spray GLP-1 Startup(2 posts)→
More from Venture
- TinyFish Launches TinyResearch and TinySet for Deep Web Work — rohanpaul_ai · 2026-11-06
- 45% of Consumers Now Ask AI for Local Business Recommendations — tomcrawshaw01 · 2026-11-06
- Investor runs 10,000 AI-generated scenarios on CAVA with SuperAnalyst and Canalyst models — RihardJarc · 2026-11-06
- Micron hits 3-month low as chip rout follows top Democrat's call to pause AI development — IndependentCoast3974 · 2026-11-06
- Next year will be the year of robotics evaluation — cool demos alone won't raise funding — DJiafei · 2026-11-06
- SEO playbook: mine GSC GenAI report for AIO queries, target videos over blog posts — lilyraynyc · 2026-11-06